BNP Paribas Financial Markets
TARO

BNP Paribas Financial Markets’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

BNP Paribas Financial Markets’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,107
Closed -$174K – 4239
2024
Q1 		$174K Buy
4,107
+1,799
+78% +$75.8K ﹤0.01% 3287
2023
Q4 		$96.4K Buy
2,308
+1,078
+88% +$39.7K ﹤0.01% 3405
2023
Q3 		$46.4K Sell
1,230
-903
-42% -$33.9K ﹤0.01% 3478
2023
Q2 		$80.9K Buy
+2,133
New +$67K ﹤0.01% 3328
2022
Q4 		– Sell
-90
Closed -$2.7K – 4762
2022
Q3 		$2.7K Sell
90
-64
-42% -$2.21K ﹤0.01% 4317
2022
Q2 		$5.57K Buy
154
+51
+50% +$1.94K ﹤0.01% 3813
2022
Q1 		$4.46K Buy
+103
New +$4.81K ﹤0.01% 3863
2019
Q2 		– Sell
-22
Closed -$2.38K – 4607
2019
Q1 		$2.38K Hold
22
– – ﹤0.01% 4114
2018
Q4 		$1.86K Hold
22
– – ﹤0.01% 3813
2018
Q3 		$2.16K Sell
22
-1,745
-99% -$189K ﹤0.01% 4247
2018
Q2 		$204K Sell
1,767
-1,714
-49% -$188K ﹤0.01% 2427
2018
Q1 		$344K Buy
3,481
+1,745
+101% +$177K ﹤0.01% 2457
2017
Q4 		$182K Hold
1,736
– – ﹤0.01% 3009
2017
Q3 		$196K Sell
1,736
-4,117
-70% -$448K ﹤0.01% 2470
2017
Q2 		$656K Sell
5,853
-3,418
-37% -$386K ﹤0.01% 1763
2017
Q1 		$1.08M Sell
9,271
-1,615
-15% -$179K ﹤0.01% 1318
2016
Q4 		$1.15M Buy
10,886
+771
+8% +$80.8K 0.01% 1237
2016
Q3 		$1.12M Buy
10,115
+6,455
+176% +$855K ﹤0.01% 891
2016
Q2 		$533K Sell
3,660
-277
-7% -$39.3K ﹤0.01% 1487
2016
Q1 		$564K Sell
3,937
-7,159
-65% -$1.02M ﹤0.01% 1167
2015
Q4 		$1.71M Buy
11,096
+5,148
+87% +$752K ﹤0.01% 969
2015
Q3 		$850K Buy
5,948
+5,494
+1,210% +$768K ﹤0.01% 1100
2015
Q2 		$65.2K Buy
454
+430
+1,792% +$61.3K ﹤0.01% 2325
2015
Q1 		$3.38K Buy
24
+1
+4% +$154 ﹤0.01% 3338
2014
Q4 		$3.41K Buy
+23
New +$3.38K ﹤0.01% 1837

Other funds holding TARO

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
LI
LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return
GCM
Gladius Capital Management Chicago, Illinois $1.65B AUM 25.75% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

BNP Paribas Financial Markets's TARO Position: Q2 2024 in Review

BNP Paribas Financial Markets sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2024, closing a stake of 4,107 shares — an estimated $174K sold.

BNP Paribas Financial Markets first reported a position in TARO in Q4 2014 and held it in 25 quarters. The position peaked at $1.71M in Q4 2015. 16 funds tracked by Wall St. Rank hold TARO as of Q2 2024.

  • BNP Paribas Financial Markets reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2024 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 4,107 Taro Pharmaceutical Industries Ltd. shares in Q2 2024, an estimated $174K.
  • BNP Paribas Financial Markets first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2014 and held it in 25 quarters.
  • BNP Paribas Financial Markets's Taro Pharmaceutical Industries Ltd. position peaked at $1.71M in Q4 2015.
  • 16 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2024.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2024, filed 13 Aug 2024.